megakaryocytic


Also found in: Medical, Wikipedia.
Related to megakaryocytic: megakaryocytic leukemia

megakaryocytic

(ˌmɛɡəˌkærɪəˈsɪtɪk)
adj
(Physiology) relating to, designating, or involving megakaryocytes
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.megakaryocytic - of or pertaining to large bone marrow cellsmegakaryocytic - of or pertaining to large bone marrow cells
References in periodicals archive ?
Bone marrow examination revealed megakaryocytic hyperplasia and JAK2 V617F mutation.
10] Platelet volume is calculated as MPV and is a surrogate marker for bone marrow activity; increased megakaryocytic activity is indicated by high MPV values.
EPO also effects the megakaryocytic colony stimulating factors, acetylhydroase (PAF-AH) and paraoxonase (PON1).
Dispersed among the fat cells were non-uniform hematopoietic areas containing granulocytic, erythrocytic, and megakaryocytic elements (Figure 2).
Panmyelosis was present in all of the biopsies and characteristic megakaryocytic pleomorphism was appreciated.
8%) (12) Megakaryocytic Hyperplasia and dysplasia (100%) (micromegakaryocytes) (6,12) Immunophenotype Not known Other genetic abnormalities Not known Type of MDS or AML De novo MDS > t-MDS Duration of Short-7 mo (10) transformation to AML Response to treatment Resistant (3,12) Overall survival 12.
In contrast, 40HA seemed to act as an immunostimulatory agent, as suggested by the increased relative spleen weight, the number of megakaryocytic nests and the production of OVA-specific antibodies in 40HA-treated mice.
1 This condition was previously termed as idiopathic thrombocytopenia purpura, now it is well known that in most of the cases cause is not idiopathic but autoimmune with antibodies against platelets being detected in patients and associated with high megakaryocytic mass in bone marrow.
Bone marrow biopsy may reveal hypercellularity with relative myeloid hypoplasia with or without megakaryocytic hyperplasia (16).
canis antigenic load was not evaluated therefore active or acute stages of the disease were not determined, not allowing for entirely interpreting megakaryocytic alterations in bone marrow.